Recent Advances in Cell-Based Nanotherapy for Cardiovascular Diseases

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Research

Background:

• Cell-based nanotherapy offers advanced solutions for human diseases, particularly cardiovascular diseases (CVDs).
• Cell membrane coating enhances nanoparticles for improved biocompatibility, immune evasion, and targeting.
• Extracellular vesicles (EVs) are implicated in CVD progression and present therapeutic potential.

Purpose of the Study:

• To review recent advancements in cell-based nanotherapy for cardiovascular diseases (CVDs).
• To highlight extracellular vesicles (EVs) and biomimetic nanoplatforms for CVD diagnosis and treatment.
• To discuss the challenges and future directions of nanotherapy in cardiovascular medicine.

Main Methods:

• Literature review of cell-based nanotherapy strategies for CVDs.
• Focus on cell membrane-derived nanoparticles and extracellular vesicles (EVs).
• Analysis of biomedical applications in CVD diagnosis and targeted treatment.

Main Results:

• Cell membrane coating confers superior biocompatibility, immune evasion, and specificity to nanoparticles.
• Extracellular vesicles (EVs) demonstrate significant potential for cargo delivery in CVD contexts.
• Biomimetic nanoplatforms derived from natural cells show promise for CVD diagnosis and therapy.

Conclusions:

• Cell-based nanotherapy, particularly using EVs and biomimetic platforms, is a promising avenue for cardiovascular disease (CVD) management.
• Further research is needed to overcome challenges and fully realize the therapeutic potential of these nanotechnologies.
• Targeted delivery and enhanced biocompatibility are key advantages for nanomedicine in CVD treatment.